Immunic
IMUX
63 hedge funds and large institutions have $50.7M invested in Immunic in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
37% more capital invested
Capital invested by funds: $36.9M → $50.7M (+$13.8M)
7% more funds holding
Funds holding: 59 → 63 (+4)
1.03% less ownership
Funds ownership: 5.58% → 4.55% (-1%)
25% less call options, than puts
Call options by funds: $428K | Put options by funds: $570K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$816K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$286K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$249K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$177K |
| 5 |
IAM
Innovis Asset Management
Chicago,
Illinois
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$3.71M |
| 2 |
AG
Artal Group
Luxembourg
|
-$1.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.06M |
| 4 |
Morgan Stanley
New York
|
-$783K |
| 5 |
AC
AWH Capital
Dallas,
Texas
|
-$745K |
IMUX Hedge Fund Activity: Q2 2023 in Review
63 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2023, worth a combined $50.7M — up 37% from $36.9M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IMUX positions and 8 closed out — a net gain of 4 holders — while 20 added to existing stakes and 12 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $816K. The largest seller was Deep Track Capital, cutting an estimated $3.71M.
- 63 institutional investors held Immunic (IMUX) as of Q2 2023, up from 59 in Q1 2023.
- Funds reported $50.7M of Immunic stock for Q2 2023, up 37% quarter-over-quarter.
- 12 funds opened new Immunic positions in Q2 2023 and 8 closed out, a net change of +4 holders.
- The largest Immunic buyer in Q2 2023 was Acadian Asset Management, an estimated $816K added.
- The largest Immunic seller in Q2 2023 was Deep Track Capital, an estimated $3.71M sold.
Based on aggregated 13F filings for Q2 2023.